Microbial Collagenase clinical trials
Also written Xiaflex, Collagenase Clostridium Histolyticum, AA4500 and EN3835.
Includes 4 studies of Xiapex.
How each study uses Microbial Collagenase is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Microbial Collagenase studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 4 Jun 1965 · SANTYL · BLA 101995 (FDA, Drugs@FDA)
- European Union
- 28 Feb 2011 · Xiapex · EMEA/H/C/002048 (EMA; as xiapex; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
Studies by the year they started
71 studies that test it; most in 2010 (9)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2007 | 5 |
| 2008 | 1 |
| 2010 | 9 |
| 2011 | 6 |
| 2012 | 7 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 51 · Other 20
Endo Pharmaceuticals (34) · Endo USA Inc., a Keenova Therapeutics Company (5) · Healthpoint (4) · Charitable Union for the Research and Education of Peyronie's Disease (3) · Smith & Nephew, Inc. (3) · Indiana Hand to Shoulder Center (2) · University of Miami (1) · Tampere University (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test Microbial Collagenase.
- Jan 2027Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's DiseasePhase 4 · University of Miami
- Feb 2027Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie'sPhase 4 · Charitable Union for the Research and Education of Peyronie's Disease
Studies
Open first, then newest update. How each study uses Microbial Collagenase is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 71
- Study to Assess the Long-term Safety of KN3835 in the Treatment and Retreatment of Flexible/Semi-Flexible Hammertoe (HMT)RecruitingPhase 3Endo USA Inc., a Keenova Therapeutics CompanyNCT07846280Written as KN3835
- Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)RecruitingPhase 3Endo USA Inc., a Keenova Therapeutics CompanyNCT07759362Written as KN3835
- Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)CompletedPhase 3Endo USA Inc., a Keenova Therapeutics CompanyNCT06151197Written as EN3835
- Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's DiseaseActive, not recruitingPhase 4Charitable Union for the Research and Education of Peyronie's DiseaseNCT06649539Written as Collagenase Clostridium Histolyticum
- Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie'sActive, not recruitingPhase 4Charitable Union for the Research and Education of Peyronie's DiseaseNCT04786106Written as Collagenase Clostridium Histolyticum 0.9 MG [Xiaflex] (CCH)
- Efficacy of a Novel CCH Protocol for PD Among Prior Non-respondersCompletedPhase 4Charitable Union for the Research and Education of Peyronie's DiseaseNCT05108558Written as CCH administration
- Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's DiseaseActive, not recruitingPhase 4University of MiamiNCT05777031Written as Collagenase Clostridium Histolyticum (CCH)
- Trial Comparing Treatment Strategies in Dupuytren's ContractureActive, not recruitingPhase 4Tampere UniversityNCT03192020Written as Collagenase Clostridium Histolyticum (CCH) 2.9 MG/ML [Xiaflex]
- Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar FibromatosisCompletedPhase 2Endo USA Inc., a Keenova Therapeutics CompanyNCT05152173Written as EN3835
- A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA)CompletedPhase 2Endo USA Inc., a Keenova Therapeutics CompanyNCT06169319Written as Collagenase Clostridium Histolyticum (CCH)
- Fasciectomy vs Collagenase Injection in Recurrent Dupuytren DiseaseActive, not recruitingPhase 4Region SkaneNCT03406338Written as Collagenase Clostridium Histolyticum
- Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar FibromatosisCompletedPhase 3Endo PharmaceuticalsNCT05254457Written as EN3835
- Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the ButtocksCompletedPhase 2Endo PharmaceuticalsNCT05419505Written as CCH-aaes
- Effectiveness of Splinting After Collagenase InjectionCompletedPhase 3Foundation for Orthopaedic Research and EducationNCT04874870Written as Collagenase Clostridium Histolyticum 0.9 MG [Xiaflex]
- Clostridium Histolyticum Collagenase Injection for Urethral DiseaseCompletedPhase 2University of South FloridaNCT02948842Written as Clostridium Histolyticum Collagenase
- Focused Shock Wave Therapy Outcomes in Peyronie's Disease and Erectile DysfunctionWithdrawnNot applicableMayo ClinicNCT05646602Written as Collagenase Clostridium Histolyticum
- Safety and Efficacy of EN3835 in Participants With Frozen ShoulderCompletedPhase 2Endo PharmaceuticalsNCT04496167Written as EN3835
- Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)CompletedPhase 3Endo PharmaceuticalsNCT03526549Written as CCH-aaes
- Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)CompletedPhase 2Endo PharmaceuticalsNCT03632993Written as collagenase clostridium histolyticum (CCH)
- Effect of Oral TXA on Buttock Bruising Post CCH Injections in Adult FemalesCompletedPhase 4LuxurgeryNCT05309525Written as Collagenase Clostridium Histolyticum-Aaes
See all 71 studies that test Microbial Collagenase →
Given beside what is tested · 2 — Microbial Collagenase is usual care or a partner of the new treatment
- Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's DiseaseRecruitingNot applicableMayo ClinicNCT06065436Written as Collagenase Clostridium Histolyticum
- An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's DiseaseCompletedPhase 3Endo PharmaceuticalsNCT02267460Written as AA4500
As the comparator · 1 — what is tested is compared with Microbial Collagenase
What changed recently
From the registry's own updates since Oct 18, 2026.
Started recruiting1
Codes
What other systems call Microbial Collagenase · ClinicalTrials.gg INT007238
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003012 | Microbial Collagenase | One source ClinicalTrials.gov |
| RxNorm | 898492 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.